Diabetes mellitus and cancer risk: Review of the epidemiological evidence

被引:195
|
作者
Shikata, Kentaro [1 ]
Ninomiya, Toshiharu [2 ]
Kiyohara, Yutaka [1 ]
机构
[1] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka, Japan
[2] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka, Japan
来源
CANCER SCIENCE | 2013年 / 104卷 / 01期
关键词
POPULATION-BASED COHORT; HELICOBACTER-PYLORI INFECTION; GENERAL JAPANESE POPULATION; NECROSIS-FACTOR-ALPHA; BREAST-CANCER; INSULIN-RESISTANCE; PROSTATE-CANCER; GASTRIC-CANCER; HEPATOCELLULAR-CARCINOMA; ENDOMETRIAL CANCER;
D O I
10.1111/cas.12043
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Diabetes mellitus and cancer are diseases of epidemic proportions across the globe. These diseases are influenced by many factors, both genetic and environmental. A possible association between diabetes and cancer risk has long been speculated. Increased incidence of several cancers has been observed in diabetes patients, notably pancreatic, hepatic, colorectal, breast, urinary tract, and endometrial cancers. In contrast, a decreased incidence of prostate cancer is observed in diabetes patients, implying a protective effect. Precise knowledge of the complex associations and interactions between these two conditions is of great importance for their prevention and treatment. Multiple potential mechanisms have been proposed, but they have tended to be site-specific. Possible common mechanisms for a biological link between diabetes and cancer include hyperinsulinemia, hyperglycemia, and inflammation. Today, 366 million people live with diabetes globally, and this figure is expected to increase. Thus, if diabetes is associated with even a small increase in cancer risk, this may have important consequences at the population level. The aim of this review is to summarize recent epidemiological evidence of an association between diabetes and total cancer and specific sites of cancer, and to consider causal associations between these diseases. (Cancer Sci 2013; 104: 914)
引用
收藏
页码:9 / 14
页数:6
相关论文
共 50 条
  • [31] Diabetes mellitus, medications for type 2 diabetes mellitus, and cancer risk
    La Vecchia, Carlo
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2011, 60 (10): : 1357 - 1358
  • [32] Diabetes Mellitus and the risk of prostate cancer
    Rosenberg, DJ
    Neugut, AI
    Ahsan, H
    Shea, S
    CANCER INVESTIGATION, 2002, 20 (02) : 157 - 165
  • [33] Diabetes mellitus and prostate cancer risk
    Mullins, Jeffrey K.
    Loeb, Stacy
    EXPERT REVIEW OF ENDOCRINOLOGY & METABOLISM, 2010, 5 (06) : 787 - 789
  • [34] Diabetes Mellitus and Colorectal Cancer Risk
    Kallergi, Aggela
    Chambre, Claire
    Duchemann, Boris
    Fysekidis, Marinos
    Bihan, Helene
    CURRENT COLORECTAL CANCER REPORTS, 2015, 11 (04) : 209 - 216
  • [35] Diabetes mellitus: influences on cancer risk
    Szablewski, Leszek
    DIABETES-METABOLISM RESEARCH AND REVIEWS, 2014, 30 (07) : 543 - 553
  • [36] Diabetes mellitus and prostate cancer risk
    Pierce, Brandon L.
    Plymate, Stephen
    Ostrander, Elaine A.
    Stanford, Janet L.
    PROSTATE, 2008, 68 (10): : 1126 - 1132
  • [37] Diabetes mellitus and colorectal cancer risk
    La Vecchia, C
    Negri, E
    Decarli, A
    Franceschi, S
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 1997, 6 (12) : 1007 - 1010
  • [39] An updated review of the epidemiological evidence that cigarette smoking increases risk of colorectal cancer
    Giovannucci, E
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2001, 10 (07) : 725 - 731
  • [40] Proton Pump Inhibitors and Cancer Risk: A Comprehensive Review of Epidemiological and Mechanistic Evidence
    Sawaid, Ibrahim O.
    Samson, Abraham O.
    JOURNAL OF CLINICAL MEDICINE, 2024, 13 (07)